Enerpac Tool Group, Singular Genomics Systems And 3 Stocks To Watch On Monday
Portfolio Pulse from Avi Kapoor
Enerpac Tool Group, Singular Genomics Systems, Beyond Air, Iteris, and Stoke Therapeutics are stocks to watch on Monday. Enerpac Tool Group is expected to report earnings, Singular Genomics announced a reverse stock split, Beyond Air is expected to post a quarterly loss, Iteris filed for a mixed securities shelf offering, and Stoke Therapeutics' COO will step down.
June 24, 2024 | 7:32 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Iteris filed for a $150 million mixed securities shelf offering. Shares fell 1.2% to $4.0201 in after-hours trading.
The filing for a mixed securities offering often dilutes existing shares, leading to a short-term decrease in stock price.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 100
NEGATIVE IMPACT
Singular Genomics Systems announced a 1-for-30 reverse stock split. Shares fell 9.3% to $0.3180 in after-hours trading.
Reverse stock splits are often viewed negatively by investors, leading to a significant drop in share price.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Stoke Therapeutics' COO Huw Nash will step down but continue as Chief Business Officer. Shares fell 3.6% to $14.23 on Friday.
Leadership changes can create uncertainty, leading to a short-term negative impact on stock price.
CONFIDENCE 70
IMPORTANCE 40
RELEVANCE 100
POSITIVE IMPACT
Enerpac Tool Group is expected to report quarterly earnings of 47 cents per share on revenue of $153.20 million. Shares gained 1.9% to $39.22 in after-hours trading.
Positive earnings expectations and after-hours price increase suggest a likely short-term upward movement in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Beyond Air is expected to post a quarterly loss of $0.48 per share on revenue of $747.20 thousand. Shares gained 8.1% to $1.34 in after-hours trading.
Despite the expected loss, the after-hours price increase suggests positive investor sentiment, likely leading to a short-term price rise.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 100